Serum Endocan and Carotid Intima-Media Thickness Evaluation in Male Androgenetic Alopecia Patients

Afify, Gehad; Sorour, Neveen Emad; Hussein, Mohamed; Ahmad, Enas; Darwish, Mohamed

doi:10.21608/bjas.2023.191854.1054

	Serum Endocan and Carotid Intima-Media Thickness Evaluation in Male Androgenetic Alopecia Patients
Benha Journal of Applied Sciences
Article 22, Volume 8, Issue 3, March 2023, Page 197-202 PDF (506.72 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2023.191854.1054
View on SCiNiTO
Authors
Gehad Afify ¹; Neveen Emad Sorour¹; Mohamed Hussein¹; Enas Ahmad²; Mohamed Darwish³
¹Dermatology, Venereology and Andrology Dept., Faculty of Medicine, Benha University
²Clinical and Chemical Pathology Dept. , Faculty of Medicine, Benha University
³Cardiology Dept., Faculty of Medicine, Benha University
Abstract
Background and aim of the work: Patients with androgenetic alopecia (AGA) was correlated with higher prevalence of insulin resistance, hypertension, coronary artery disease, obesity, atherosclerosis and aberrant serum lipid profile. Endocan is a possible immunoinflammatory indicator associated with cardiovascular disease. Patients with AGA appear to be at an increased risk of developing CAD, therefore, clinical evaluation of cases with AGA of grade II is recommended The carotid intima-media thickness (CIMT) is a powerful indicator of future cerebrovascular and cardiovascular disorders. This research intended to examine serum level of endocan and CIMT in male AGA patients. Patients and Methods: that research conducted in Dermatology Department, Benha University Hospital, on sixty AGA participants with 20Y old age and gender-matched individuals during the period from January 2021 to August 2021. Results: endocan level was considerably lower in control compared to AGA group, but no critical change was seen among groups concerning CIMT. Conclusion: Serum endocan was considerably lower in control compared to AGA group, but concerning CIMT, a non-critical change was seen among groups.
Keywords
CIMT; Serum Endocan; Male Androgenetic Alopecia


Statistics Article View: 254 PDF Download: 256